Regulatory Intelligence
Comprehensive FDA, EMA, CDSCO, and PMDA tracking with predictive outcome models for regulatory strategy optimization
MedLii™ = Meta Intelligence Interface
Solution Overview
Our Regulatory Intelligence solution provides comprehensive monitoring and analysis of global regulatory activities across FDA, EMA, CDSCO, PMDA, and other major authorities. This AI-powered platform delivers real-time alerts, predictive outcome models, and strategic recommendations to optimize regulatory pathways and accelerate approvals.
By combining advanced AI analytics with deep regulatory expertise, we help pharmaceutical companies navigate complex regulatory landscapes, anticipate policy changes, and make data-driven decisions that reduce development timelines and improve approval probabilities.
Global Regulatory Coverage
FDA
Food & Drug Administration
- • CDER drug approvals
- • CBER biologics
- • CDRH devices
- • Guidance documents
EMA
European Medicines Agency
- • Centralized approvals
- • CHMP recommendations
- • PRIME scheme
- • Scientific advice
CDSCO
Central Drugs Standard Control
- • DCGI approvals
- • Clinical trial permissions
- • Import licenses
- • Manufacturing approvals
PMDA
Pharmaceuticals & Medical Devices
- • NDA approvals
- • Sakigake designation
- • Conditional approvals
- • PMDA consultation
Intelligence Capabilities
Predictive Outcome Models
AI-powered models that predict approval probabilities, timeline estimates, and potential regulatory hurdles.
- • Approval probability scoring
- • Timeline forecasting
- • Risk factor identification
- • Success rate benchmarking
Real-Time Alert System
Instant notifications on regulatory changes, guidance updates, and competitor approvals that impact your portfolio.
- • Customizable alert filters
- • Priority-based notifications
- • Impact assessment scoring
- • Action recommendations
Strategic Recommendations
Actionable insights for regulatory strategy optimization, pathway selection, and submission planning.
- • Optimal pathway analysis
- • Submission timing guidance
- • Regulatory strategy optimization
- • Risk mitigation recommendations
Strategic Applications
Development Planning
Optimize clinical development programs with regulatory pathway analysis and timeline forecasting.
Submission Strategy
Design optimal regulatory submission strategies with precedent analysis and success probability modeling.
Competitive Intelligence
Monitor competitor regulatory activities and anticipate competitive threats or opportunities.
Market Entry Planning
Plan global market entry strategies with regulatory requirement analysis and timeline optimization.
Success Stories
Oncology Drug Accelerated Approval
Big Pharma Client • 2024
Utilized regulatory intelligence to secure accelerated approval pathway, reducing review time by 8 months and achieving priority review designation.
Rare Disease Orphan Designation
Biotech Client • 2024
Identified optimal regulatory pathway for rare disease therapy, securing both orphan drug designation and PRIME eligibility.
Platform Features
- 12+ regulatory authorities
- Real-time monitoring
- Predictive analytics
- Alert system
- Strategic recommendations
- Compliance tracking